ATE452644T1 - Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung - Google Patents
Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkungInfo
- Publication number
- ATE452644T1 ATE452644T1 AT03791169T AT03791169T ATE452644T1 AT E452644 T1 ATE452644 T1 AT E452644T1 AT 03791169 T AT03791169 T AT 03791169T AT 03791169 T AT03791169 T AT 03791169T AT E452644 T1 ATE452644 T1 AT E452644T1
- Authority
- AT
- Austria
- Prior art keywords
- site
- glutamate
- mixture
- saponins
- herbal extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Otolaryngology (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN779MU2002 | 2002-08-28 | ||
PCT/IN2003/000289 WO2004019960A2 (en) | 2002-08-28 | 2003-08-27 | Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE452644T1 true ATE452644T1 (de) | 2010-01-15 |
Family
ID=31972132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03791169T ATE452644T1 (de) | 2002-08-28 | 2003-08-27 | Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung |
Country Status (10)
Country | Link |
---|---|
US (1) | US20050249831A1 (de) |
EP (1) | EP1556062B1 (de) |
JP (1) | JP2006501251A (de) |
AT (1) | ATE452644T1 (de) |
AU (1) | AU2003276686B2 (de) |
CA (1) | CA2497161A1 (de) |
DE (1) | DE60330698D1 (de) |
NZ (1) | NZ538518A (de) |
WO (1) | WO2004019960A2 (de) |
ZA (1) | ZA200502461B (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100594027C (zh) * | 2001-12-05 | 2010-03-17 | 张喜田 | 番木鳖碱、马钱子碱和一叶秋碱及其盐的透皮剂 |
US20080182801A1 (en) | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
GB0329667D0 (en) | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
GB0513881D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
WO2006007741A1 (de) * | 2004-07-16 | 2006-01-26 | Thoeny Rolf | Flüssigwaschmittel auf saponinbasis |
GB0513888D0 (en) | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
DE102007006122A1 (de) * | 2007-02-02 | 2008-08-07 | Krewel Meuselbach Gmbh | Cistusextrakte |
EP2285821B1 (de) | 2008-06-17 | 2014-12-17 | Pawan Kumar Goel | Neuartiges verfahren zur extraktion von furostanol-saponinen aus bockshornkleesamen |
US20100316752A1 (en) * | 2009-06-10 | 2010-12-16 | Heng-Jui Hsu | Method for extracing substances from soapberry fruit and seed and products made therefrom |
WO2019182745A1 (en) * | 2018-03-19 | 2019-09-26 | Bryn Pharma, LLC | Epinephrine spray formulations |
CN110025623A (zh) * | 2019-03-21 | 2019-07-19 | 李和伟 | 一种冻干制剂及其制备方法和应用 |
EP4316461A1 (de) * | 2022-08-05 | 2024-02-07 | BRAIN Biotech AG | Konservierungszusammensetzung |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61267528A (ja) * | 1984-11-26 | 1986-11-27 | Yamanouchi Pharmaceut Co Ltd | 吸収促進剤を含有するカルシトニン経鼻剤 |
JPH02262510A (ja) * | 1987-08-11 | 1990-10-25 | Inahata Koryo Kk | 歯ミガキ組成物 |
MX9606493A (es) * | 1994-06-24 | 1997-03-29 | Nippon Shinyaku Co Ltd | Derivado de triterpeno y composicion medicinal. |
JPH09169648A (ja) * | 1995-12-22 | 1997-06-30 | Nippon Shinyaku Co Ltd | 医薬組成物 |
JP2003535830A (ja) * | 2000-05-25 | 2003-12-02 | ルピン・リミテッド | ムクロジおよびアマラキ抽出物を含む抗片頭痛用組み合わせ |
-
2003
- 2003-08-27 DE DE60330698T patent/DE60330698D1/de not_active Expired - Lifetime
- 2003-08-27 CA CA002497161A patent/CA2497161A1/en not_active Abandoned
- 2003-08-27 EP EP03791169A patent/EP1556062B1/de not_active Expired - Lifetime
- 2003-08-27 US US10/525,992 patent/US20050249831A1/en not_active Abandoned
- 2003-08-27 NZ NZ538518A patent/NZ538518A/en unknown
- 2003-08-27 AT AT03791169T patent/ATE452644T1/de not_active IP Right Cessation
- 2003-08-27 JP JP2004532654A patent/JP2006501251A/ja active Pending
- 2003-08-27 AU AU2003276686A patent/AU2003276686B2/en not_active Ceased
- 2003-08-27 WO PCT/IN2003/000289 patent/WO2004019960A2/en active Application Filing
-
2005
- 2005-03-24 ZA ZA200502461A patent/ZA200502461B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2003276686B2 (en) | 2009-03-26 |
WO2004019960A3 (en) | 2004-05-13 |
JP2006501251A (ja) | 2006-01-12 |
EP1556062B1 (de) | 2009-12-23 |
CA2497161A1 (en) | 2004-03-11 |
AU2003276686A1 (en) | 2004-03-19 |
WO2004019960A2 (en) | 2004-03-11 |
NZ538518A (en) | 2008-10-31 |
DE60330698D1 (de) | 2010-02-04 |
US20050249831A1 (en) | 2005-11-10 |
ZA200502461B (en) | 2005-11-01 |
EP1556062A2 (de) | 2005-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE452644T1 (de) | Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung | |
WO2003087094A3 (en) | Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors | |
HUP0301688A3 (en) | Amino alcohol derivatives, process for their preparation and pharmaceutical compositions containing them | |
BR0108678A (pt) | Novos compostos | |
HUP0301344A3 (en) | Non-steroidal inflammation inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP0103767A3 (en) | Use of estrogen agonist/antagonist for preparation of pharmaceutical compositions available for treating osteoarthritis | |
NO331093B1 (no) | Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav. | |
NO982729L (no) | Antagonister av det gonadotropinfrigj°rende hormon | |
HUP0300434A3 (en) | Oxazole derivatives and their uses as tyrosine kinase inhibitors, process for their preparation and pharmaceutical compositions containing them | |
HUP0203836A3 (en) | 1,3-disubstituted pyrrololidines as alpha-2-adrenoceptor antagonists, process for their preparation and pharmaceutical compositions containing them and their use | |
GR20040100121A (el) | Συνθεσεις περιεχουσες αγωνιστη υποδοχεων s1p | |
WO2006033700A3 (en) | Her2 antibody composition | |
WO2003061584A3 (en) | Novel substituted benzimidazole dosage forms and method of using same | |
ES2196063T3 (es) | Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales. | |
MXPA01012882A (es) | Composiciones y metodos que comprenden gluconato de morfina. | |
BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
PL367094A1 (en) | Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins | |
CA2360313A1 (en) | Glucocorticoid receptor modulators | |
BR0214199A (pt) | Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração | |
GB9917822D0 (en) | Nmda antagonist | |
WO2001001972A3 (en) | SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | |
EP1262196A3 (de) | Kombination eines Inhibitoren der Monoaminwiederaufnahme und eines Opioidanatagonisten zur Verwendung in Alkoholismus und Alkoholsucht | |
BR9806754A (pt) | Composições paroxetine. | |
BR0317623A (pt) | Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram | |
WO2004094400A3 (en) | Substituted benzopyrans as selective estrogen receptor-beta agonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |